Myriad Genetics Recent News
Biotech And Natural Gas ETFs On A Roll
Market Wrap For February 7: Jobs Report Not Great, But Not Too Bad
Market Wrap For December 30: Markets Quiet Ahead of New Year's Eve
PetSmart and Other Secular Growth Picks (ACT, MYGN, PETM, HLF)
Auriga Downgrades Myriad Genetics to Hold, Reduces PT to $25
Auriga Downgrades Myriad Genetics To Hold, Lowers PT To $25
Jefferies Provides Color on Myriad Genetics, Buy
Goldman Sachs Upgrades PT On Myriad Genetics To $19, Maintains Sell (MYGN)
Morgan Stanley Comments On Myriad Genetics Strong 3Q
J.P. Morgan Comments On Myriad Genetics Risk/Reward Balanced
Global Hunter Maintains Neutral on Myriad Genetics (MYGN)
Goldman Sachs Reports Myriad Genetics Oral Arguments Hold Few Surprises
Piper Jaffray Raises PT On Myriad Genetics To $20
Myriad Genetics Exceed Estimates But Guidance Is Mixed